intravitreal aflibercept
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for intravitreal aflibercept, covering 2019-05-07 to 2021-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy [Phase 2]